资讯
21 小时
MedPage Today on MSNWin for Added Relacorilant in Platinum-Resistant Ovarian CancerOlawaiye noted that the combination is a "well-tolerated regimen and we believe it should be a new standard for ...
A guideline-recommended 6-week regimen of corticosteroids for pneumonitis associated with immunotherapy significantly ...
21 小时
MedPage Today on MSNViral Immunotherapy Reduces Recurrences in Early Prostate CancerAn investigational viral immunotherapy (CAN-2409; aglatimagene besadenovec) combined with a prodrug improved disease-free ...
New data support the role of structured exercise and low inflammatory diets to improve survival and quality of life following ...
The novel drug reduces the need for burdensome phlebotomy and also addresses fatigue, thereby improving quality of life for ...
1 天
MedPage Today on MSNNon-Hormonal Drug Reduced Hot Flashes From Endocrine Therapy for Breast CancerCHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...
1 天
MedPage Today on MSNMyeloma Trial Results Spark Talk of 'Potential Cure'CHICAGO -- A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel; ...
Anlotinib plus chemotherapy demonstrated similar efficacy as bevacizumab plus chemotherapy for certain patients with ...
ASCO annual meeting featured a urothelial carcinoma oral abstract session and a discussant presentation by Dr. John Sfakianos ...
Gilead has already announced intentions to bring the data, which demonstrated a 35 percent reduction in risk of progression ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果